Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

Monitoring blood glucose levels should be a part of a daily routine, especially for people with Type 1 or Type 2 diabetes. If you find the typical ... ACTOFIT uses a continuous glucose monitor ...

Restricting eating to an 8-hour window improves blood glucose no matter whether the eating window is early or late in the day in people at risk for type 2 diabetes.

Given every human being is totally unique, it’s no surprise our bodies often behave in different ways. So, while you should ...

The Food and Drug Administration cleared Abbott’s Freestyle Libre 2 and 3 for integration with AID systems in March 2023. Earlier this year, Abbott integrated its FreeStyle Libre 2 Plus sensor with ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

The results were further supported by data from continuous glucose monitoring (CGM; Freestyle Libre Pro iQ), which was used by approximately 80% of patients in the study and reported in a separate ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

Diet plays such a crucial role in managing – and, in some cases, reversing – prediabetes that you ignore it at your peril.